Highlights Sanofi

Equities

SAN

FR0000120578

Pharmaceuticals

Market Closed - Euronext Paris Other stock markets 11:35:13 2025-04-24 am EDT			Pre-market 01:24:07 am
93.35 ^EUR	+0.12%		94.23	+0.94%

12:39am	Sobi, Sanofi Extend Hemophilia Aid Partnership	MT
Apr. 24	Drugmakers brace for Trump tariffs, while weighing numerous other worries	RE

Highlights

Sobi, Sanofi Extend Hemophilia Aid Partnership	12:39am	MT
Drugmakers brace for Trump tariffs, while weighing numerous other worries	Apr. 24	RE
Sanofi Reports Earnings Results for the First Quarter Ended March 31, 2025	Apr. 24	CI
Sector Update: Health Care Stocks Steady Pre-Bell Thursday	Apr. 24	MT
Drugmakers brace for Trump tariffs, while weighing numerous other worries	Apr. 24	RE
Sanofi's Q1 Earnings, Revenue Rise; 2025 Guidance Confirmed	Apr. 24	MT
Innate Pharma, Sanofi Finalize Investment	Apr. 24	MT
Sanofi Sales, Profit Beat Expectations on Higher Demand for Skin, Asthma Drug -- Update	Apr. 24	DJ
Sanofi Shares Hit by Currency Headwinds Despite Strong Results	Apr. 24	RE
Sanofi: Q1 EPS up 17%	Apr. 24	CF
Sanofi's quarterly profit boosted by Dupixent and newer drugs; forecast unchanged	Apr. 24	RE
Sanofi's quarterly profit boosted by Dupixent and newer drugs; forecast unchanged	Apr. 24	RE
Sanofi Posts Higher Q1 Attributable Net Income, Net Sales	Apr. 24	MT
Sanofi Sales, Profit Beat Expectations	Apr. 24	DJ
Sanofi Intends To Execute Share Buyback Program In 2025 Of EUR 5 Billion	Apr. 24	RE
Novartis, Sanofi CEOs Say EU Should Hike Drug Prices to Boost Innovation	Apr. 23	MT
Novartis, Sanofi CEOs Say EU Should Hike Drug Prices to Boost Innovation	Apr. 23	MT
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday as Trump Softens Stance on Powell, Tariffs	Apr. 23	MT
Novavax shares soar after FDA request raises hope for COVID vaccine approval	Apr. 23	RE
Trump Administration Mulls Cutting US Drug Prices to International Levels	Apr. 22	MT
Trump Mulls Cutting US Drug Prices to International Levels, Reuters Reports	Apr. 22	MT
Arecor Therapeutics sees "significant future growth" as revenue rises	Apr. 22	AN
Sanofi: new R&D unit in Marcy-l'Etoile	Apr. 22	CF
US Food and Drug Administration Approves Sanofi and Regeneron's Dupixent as First Targeted Therapy for Chronic Spontaneous Urticaria	Apr. 18	CI
Sanofi, Earendil Labs Sign Licensing Deal for Autoimmune, Inflammatory Bowel Disease Treatments	Apr. 17	MT